PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8825225-0 1995 Dextran and hydroxyethyl starch interfere with fibrinogen assays. Dextrans 0-7 fibrinogen beta chain Homo sapiens 47-57 8825225-9 1995 We conclude that the results of indirect fibrinogen assays should be interpreted cautiously, when HES or dextran is used for volume replacement. Dextrans 105-112 fibrinogen beta chain Homo sapiens 41-51 8825225-1 1995 We studied the haemostatic and volume effects of synthetic plasma substitutes and Ringer"s solution in 48 surgical patients and found that the measured fibrinogen concentrations of patients receiving either dextran or hydroxyethyl starch (HES) were significantly higher than those predicted by the dilutional effects. Dextrans 207-214 fibrinogen beta chain Homo sapiens 152-162 1173027-1 1975 It has been shown that a variety of synthetic organic anions which induce fibrinolytic activity in human plasma in vitro and which in addition inhibit collagen-induced aggregation of human platelets, also exert to various degrees an inhibition of dextran, fibrinogen and gelatin induced aggregation of human erythrocytes and of the pathologically accelerated erythrocyte sedimentation rate. Dextrans 247-254 fibrinogen beta chain Homo sapiens 256-266 989976-1 1976 Characteristic changes induced by dextran during the conversion of fibrinogen to fibrin have previously been shown to be associated with profound alterations in morphology of fibrin. Dextrans 34-41 fibrinogen beta chain Homo sapiens 67-77 1001743-0 1976 Effect of steric exclusion by dextran on the conversion of fibrinogen into fibrin. Dextrans 30-37 fibrinogen beta chain Homo sapiens 59-69 8541521-6 1995 The presence of dextran T40 in clotted fibrinogen solutions changes the clot impedance by increasing clot permeability and decreasing clot viscoelasticity. Dextrans 16-27 fibrinogen beta chain Homo sapiens 39-49 6160642-0 1980 Enhancement of plasminogen activation and hydrolysis of purified fibrinogen and fibrin by dextran 70. Dextrans 90-100 fibrinogen beta chain Homo sapiens 65-75 602311-0 1977 [Occurrence and behavior of fibrin fibrinogen degradation products in concentrates of factor VIII, cryoprecipitate and dextran precipitate during long-term preservation]. Dextrans 119-126 fibrinogen beta chain Homo sapiens 35-45 6059855-0 1967 The relationship between dextran precipitable fibrinogen and 170H corticosteroid levels in psychotic subjects. Dextrans 25-32 fibrinogen beta chain Homo sapiens 46-56 4462754-0 1974 The solubility of fibrinogen in solutions containing dextrans of various molecular weights. Dextrans 53-61 fibrinogen beta chain Homo sapiens 18-28 4462754-1 1974 The effect of dextrans of various molecular weights on the solubility of fibrinogen was investigated. Dextrans 14-22 fibrinogen beta chain Homo sapiens 73-83 5046146-8 1972 Dextran was found to act indirectly on the erythrocyte flexibility by reducing the plasma fibrinogen concentration. Dextrans 0-7 fibrinogen beta chain Homo sapiens 90-100 14433991-0 1960 The interaction of dextran with serum albumin, gamma globulin, and fibrinogen. Dextrans 19-26 fibrinogen beta chain Homo sapiens 47-77 13984284-2 1962 Contribution to the study of the influence of dextran on fibrinogen]. Dextrans 46-53 fibrinogen beta chain Homo sapiens 57-67 14441863-1 1959 Interactions of fibrinogen with dextran sulfate, dextran, and carboxymethyl cellulose were investigated by turbidity measurement, chemical analysis, and electrophoresis. Dextrans 32-39 fibrinogen beta chain Homo sapiens 16-26 14433991-1 1960 The interaction between dextran and serum albumin, gamma globulin, and fibrinogen can be studied by an electrophoretic method, which depends on obtaining electrophoretic patterns, first of each protein, then of dextran, and finally of mixtures of each protein with dextran. Dextrans 24-31 fibrinogen beta chain Homo sapiens 51-81 14433991-1 1960 The interaction between dextran and serum albumin, gamma globulin, and fibrinogen can be studied by an electrophoretic method, which depends on obtaining electrophoretic patterns, first of each protein, then of dextran, and finally of mixtures of each protein with dextran. Dextrans 211-218 fibrinogen beta chain Homo sapiens 51-81 14433991-1 1960 The interaction between dextran and serum albumin, gamma globulin, and fibrinogen can be studied by an electrophoretic method, which depends on obtaining electrophoretic patterns, first of each protein, then of dextran, and finally of mixtures of each protein with dextran. Dextrans 211-218 fibrinogen beta chain Homo sapiens 51-81 14433991-6 1960 The method shows that a mixture of dextran and fibrinogen gives only one slowly moving spike (pH 6.6 to 8.6), the area under which is the sum of the areas under the dextran and the fibrinogen spikes taken separately. Dextrans 35-42 fibrinogen beta chain Homo sapiens 181-191 14433991-6 1960 The method shows that a mixture of dextran and fibrinogen gives only one slowly moving spike (pH 6.6 to 8.6), the area under which is the sum of the areas under the dextran and the fibrinogen spikes taken separately. Dextrans 165-172 fibrinogen beta chain Homo sapiens 47-57 14947852-0 1952 Interaction of dextran and fibrinogen. Dextrans 15-22 fibrinogen beta chain Homo sapiens 27-37 14900980-0 1951 Influence of dextran on the conversion of fibrinogen to fibrin. Dextrans 13-20 fibrinogen beta chain Homo sapiens 42-52 32986054-5 2020 In this study, we report on maghemite nanoparticles functionalized with citrate-, dextran- and polyethylene glycol coatings and their interaction with the clotting protein fibrinogen. Dextrans 82-89 fibrinogen beta chain Homo sapiens 172-182 32986054-8 2020 In addition, bioconjugates of fibrinogen with dextran- and citrate-coated NPs interact with integrin-containing lipid bilayer, especially upon treatment with divalent ions, whereas PEG-coating reveals minor interaction. Dextrans 46-53 fibrinogen beta chain Homo sapiens 30-40 29661301-5 2018 Additionally, antifouling properties of carboxybetaine functionalized dextran micelles were much better than that of unmodified dextran for fibrinogen and lysozyme as tested by ITC. Dextrans 70-77 fibrinogen beta chain Homo sapiens 140-150 29661301-5 2018 Additionally, antifouling properties of carboxybetaine functionalized dextran micelles were much better than that of unmodified dextran for fibrinogen and lysozyme as tested by ITC. Dextrans 128-135 fibrinogen beta chain Homo sapiens 140-150 10946093-5 2000 Correction of clot structure anomaly, by addition of dextran 40 to fibrinogen before clotting, induces an improvement in fibrin degradation that was attributed to an increase in porosity. Dextrans 53-60 fibrinogen beta chain Homo sapiens 67-77 21093043-6 2011 We have observed the aggregation of the nanoparticles induced by fibrinogen, and found that it was prevented when the density of dextran chains protruding from the core surface was sufficiently high. Dextrans 129-136 fibrinogen beta chain Homo sapiens 65-75 15608046-13 2005 CONCLUSION: Coagulopathy induced by haemodilution with either HES 200/0.5, HES 130/0.4, and dextran 70 may be improved by fibrinogen supplementation. Dextrans 92-99 fibrinogen beta chain Homo sapiens 122-132 22120019-6 2012 Using optical tweezers-based force spectroscopy to measure non-specific protein-protein interactions, we found the dextran-coated beads nonreactive towards fibrinogen, thus providing an inert platform for biospecific modifications. Dextrans 115-122 fibrinogen beta chain Homo sapiens 156-166 20801620-2 2010 In this work, the effects of the dextran and PEG on the morphology, wetting, and surface charge of the resulting surfaces were quantified and correlated with changes in the amount of fibrinogen and albumin adsorbed from aqueous solution. Dextrans 33-40 fibrinogen beta chain Homo sapiens 183-193 20801620-8 2010 The PEG- and dextran-modified PDMS were exposed to BSA and fibrinogen to test their resistance to protein adsorption. Dextrans 13-20 fibrinogen beta chain Homo sapiens 59-69 15769543-6 2005 Dextran-coated NPs adsorbed ApoA-I and fibrinogen from plasma. Dextrans 0-7 fibrinogen beta chain Homo sapiens 39-49